Johnson & Johnson (JNJ) — Stock Valuation & Research

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr.…

JNJ key statistics

Price$271.57
Market cap$654.46B
SectorHealthcare
IndustryDrug Manufacturers - General
ExchangeNYSE
52-week range173.33-281.07
Dividend (TTM)$5.28 per share
Beta0.24

Explore JNJ's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.